Jha, M. K., Minhajuddin, A., Gadad, B. S., Chin Fatt, C., & Trivedi, M. H. (2019). Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial. Pharmaceuticals (Basel).
Styl ChicagoJha, Manish K., Abu Minhajuddin, Bharathi S. Gadad, Cherise Chin Fatt, a Madhukar H. Trivedi. "Higher S100B Levels Predict Persistently Elevated Anhedonia With Escitalopram Monotherapy Versus Antidepressant Combinations: Findings From CO-MED Trial." Pharmaceuticals (Basel) 2019.
Citace podle MLAJha, Manish K., et al. "Higher S100B Levels Predict Persistently Elevated Anhedonia With Escitalopram Monotherapy Versus Antidepressant Combinations: Findings From CO-MED Trial." Pharmaceuticals (Basel) 2019.